Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single …

T Li, Z Zhou, Z Xie, X Fan, Y Zhang, Y Zhang… - Journal of Cancer …, 2023 - Springer
Abstract Background Cancer-associated fibroblasts (CAFs) are an essential component of
the tumor immune microenvironment that are involved in extracellular matrix (ECM) …

Targeted metabolomics analyses reveal specific metabolic alterations in high-grade prostate cancer patients

N Gomez-Cebrian, M Garcia-Flores… - Journal of proteome …, 2020 - ACS Publications
Prostate cancer (PCa) is a hormone-dependent tumor characterized by an extremely
heterogeneous prognosis. Despite recent advances in partially uncovering some of the …

[HTML][HTML] Syndecan family gene and protein expression and their prognostic values for prostate cancer

NJ Santos, CN Barquilha, IC Barbosa… - International journal of …, 2021 - mdpi.com
Prostate cancer (PCa) is the leading cause of cancer-associated mortality in men, and new
biomarkers are still needed. The expression pattern and protein tissue localization of …

[HTML][HTML] The expression of YWHAZ and NDRG1 predicts aggressive outcome in human prostate cancer

S Lage-Vickers, J Bizzotto, MP Valacco… - Communications …, 2021 - nature.com
Some prostate cancers (PCas) are histo-pathologically grouped within the same Gleason
Grade (GG), but can differ significantly in outcome. Herein, we aimed at identifying molecular …

A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients

W Ebrahimizadeh, KP Guérard, S Rouzbeh… - British Journal of …, 2023 - nature.com
Background Distinguishing between true indolent and potentially life-threatening prostate
cancer is challenging in tumours displaying clinicopathologic features associated with low or …

[HTML][HTML] Identification of molecular markers associated with prostate cancer subtypes: an integrative bioinformatics approach

I Granata, P Barboro - Biomolecules, 2024 - mdpi.com
Prostate cancer (PCa) is characterised by androgen dependency. Unfortunately, under anti-
androgen treatment pressure, castration-resistant prostate cancer (CRPC) emerges …

[HTML][HTML] Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel

E Labanca, J Bizzotto, P Sanchis, N Anselmino, J Yang… - Oncogene, 2021 - nature.com
Prostate cancer (PCa) that progresses after androgen deprivation therapy (ADT) remains
incurable. The underlying mechanisms that account for the ultimate emergence of resistance …

[HTML][HTML] Prediction of biochemical recurrence-free survival of prostate cancer patients leveraging multiple gene expression profiles in tumor microenvironment

R Zhou, Y Feng, J Ye, Z Han, Y Liang, Q Chen… - Frontiers in …, 2021 - frontiersin.org
Tumor-adjacent normal (TAN) tissues, which constitute tumor microenvironment and are
different from healthy tissues, provide critical information at molecular levels that can be …

Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide

J Li, Z Hong, J Zhang, S Zheng, F Wan, Z Liu, B Dai - Oncogene, 2024 - nature.com
Androgen receptors (ARs) play key roles in prostate cancer (PCa) progression and
castration-resistant prostate cancer (CRPC) resistance to drug therapy. SET and MYND …

[HTML][HTML] DESNT: a poor prognosis category of human prostate cancer

BA Luca, DS Brewer, DR Edwards, S Edwards… - European urology …, 2018 - Elsevier
Background A critical problem in the clinical management of prostate cancer is that it is
highly heterogeneous. Accurate prediction of individual cancer behaviour is therefore not …